- Association of urinary ketamine and APOA1 levels with bladder dysfunction in ketamine abusers revealed via proteomics and targeted metabolite analyses
Jo-Chuan Liu et al, 2021, Scientific Reports CrossRef - Gene expression profiling of tumor-associated macrophages after exposure to single-dose irradiation
Wei-Hsiang Kung et al, 2017, Computational Biology and Chemistry CrossRef - Repeated Doses of Ketamine Affect the Infant Rat Urogenital System
Hulya Kasıkara et al, 2021, Drug Design, Development and Therapy CrossRef - Long‐term ketamine administration induces bladder damage and upregulates autophagy‐associated proteins in bladder smooth muscle tissue
Yanning Li et al, 2021, Environmental Toxicology CrossRef - What urologists need to know about ketamine‐induced uropathy: A systematic review
Daniele Castellani et al, 2020, Neurourology and Urodynamics CrossRef - Effects of a new β3‐adrenoceptor agonist, vibegron, on neurogenic bladder dysfunction and remodeling in mice with spinal cord injury
Daisuke Gotoh et al, 2020, Neurourology and Urodynamics CrossRef - Extracorporeal Shock Wave Therapy Protected the Functional and Architectural Integrity of Rodent Urinary Bladder against Ketamine-Induced Damage
Yen-Ta Chen et al, 2021, Biomedicines CrossRef - Molecular pathways underlying tissue injuries in the bladder with ketamine cystitis
Xiang Xie et al, 2021, The FASEB Journal CrossRef - Ketamine Misuse and Adverse Body Effects: A Focus on Uropathy
Daniele Castellani, 2022, Handbook of Substance Misuse and Addictions CrossRef - Ketamine‑induced bladder dysfunction is associated with extracellular matrix accumulation and impairment of calcium signaling in a mouse model
Cheng‑Huang Shen et al, 2019, Molecular Medicine Reports CrossRef - Molecular Mechanisms and Key Processes in Interstitial, Hemorrhagic and Radiation Cystitis
Clément Brossard et al, 2022, Biology CrossRef - Ketamine Inhalation Alters Behavior and Lower Urinary Tract Function in Mice
Shu-Yu Wu et al, 2022, Biomedicines CrossRef - Is medicinal ketamine associated with urinary dysfunction issues? Assessment of both the European Medicines Agency (EMA) and the UK Yellow Card Scheme pharmacovigilance database‐related reports
Nicolo' Schifano et al, 2021, LUTS: Lower Urinary Tract Symptoms CrossRef - Ketamine Misuse and Adverse Body Effects: A Focus on Uropathy
Daniele Castellani, 2022, Handbook of Substance Misuse and Addictions CrossRef - Transcriptomic analysis of bladder tissue in a rat model of ketamine‐induced bladder fibrosis
Haozhen Li et al, 2022, Neurourology and Urodynamics CrossRef - Cyclin‐dependent kinase 1 shows to be a potential genetic target for chemical cystitis
Kun Wang et al, 2021, Immunity, Inflammation and Disease CrossRef - Rodent models of ketamine‐induced cystitis
Saki Sultana et al, 2021, Neurourology and Urodynamics CrossRef